Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Ipilimumab × Plasma cell × Clear all

Phase

Status

Sponsor Class

OTHER 6 NIH 2 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Other solid neoplasm 1 Lymphoid 1 Gastrointestinal 1 Dermatologic 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Dexamethasone 43 Bortezomib 21 Cyclophosphamide 19 Lenalidomide 18 daratumumab 16 Calcium Dobesilate 14 Melphalan 13 Thalidomide 11 carfilzomib 7 Prednisone 7 dexamethasone acetate 6 dexamethasone 21-phosphate 6 auricularum 6 Peripheral Blood Stem Cell Transplantation 6 Doxorubicin 6 pomalidomide 5 Vincristine 4 Filgrastim 4 isatuximab 3 Interferon-alpha 3 selinexor 2 sargramostim 2 ixazomib 2 elotuzumab 2 cobimetinib 2 belantamab mafodotin 2 Steroids 2 Stem Cell Transplantation 2 Radiotherapy 2 Microarray Analysis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297606 2026-03-04

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡